Eligo Bioscience logo

Eligo Bioscience

ID: 5290133

Eligo Bioscience is a developer of novel genetic medicines founded in 2014 by Timothy Lu, Xavier Duportet, Luciano Marraffini and David Bikard.

10

Funding Rounds

$87.6m

Money raised

Overview

Eligo Bioscience is a developer of novel genetic medicines founded in 2014 by Timothy Lu, Xavier Duportet, Luciano Marraffini and David Bikard.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Eligo Bioscience has raised a total of $57.7m in funding over 10 rounds.

Key Insights:

  • Eligo Bioscience Grant Funding Round, May 2025: $5m
  • Eligo Bioscience December 2023 Series B Funding Round: $30m
  • Eligo Bioscience April 2018 Series A Funding Round: $1.9m
  • Eligo Bioscience September 2017 Series A Funding Round: $18m
  • Eligo Bioscience July 2015 Seed Funding Round: $2.8m
  • Eligo Bioscience funding round, September 2017: $20m
  • Eligo Bioscience Grant (money), January 2019: $4.72m
  • Eligo Bioscience Grant (money), September 2017: $2m
  • Eligo Bioscience Seed round, July 2015: $3.15m